Literature DB >> 8733819

The treatment of negative symptoms: pharmacological and methodological issues.

W T Carpenter1.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8733819

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


× No keyword cloud information.
  7 in total

Review 1.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 2.  Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomes.

Authors:  W W Fleischhacker; M Hummer
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

3.  Topiramate augments the antipsychotic-like effect and cortical dopamine output of raclopride.

Authors:  Amani Eltayb; Marie-Louise G Wadenberg; Björn Schilström; Torgny H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-11-12       Impact factor: 3.000

4.  Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow and NMDA receptor-mediated transmission.

Authors:  Monica M Marcus; Kent Jardemark; Anna Malmerfelt; Carl Björkholm; Torgny H Svensson
Journal:  Neuropsychopharmacology       Date:  2010-05-12       Impact factor: 7.853

5.  Comparing the efficacy of interventions that use environmental supports to improve outcomes in patients with schizophrenia.

Authors:  Dawn I Velligan; Pamela M Diamond; Natalie J Maples; James Mintz; Xueying Li; David C Glahn; Alexander L Miller
Journal:  Schizophr Res       Date:  2008-04-18       Impact factor: 4.939

6.  Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.

Authors:  Charlotte Wiker; Love Linnér; Marie-Louise Wadenberg; Torgny H Svensson
Journal:  Neuropsychiatr Dis Treat       Date:  2005-12       Impact factor: 2.570

7.  Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.

Authors:  Charlotte Wiker; Love Linnér; Marie-Louise Wadenberg; Torgny H Svensson
Journal:  Neuropsychiatr Dis Treat       Date:  2005-09       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.